Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U, Janssen KP.
Nitsche U, et al. Among authors: stein u.
Ann Surg. 2012 Nov;256(5):763-71; discussion 771. doi: 10.1097/SLA.0b013e318272de87.
Ann Surg. 2012.
PMID: 23095620